HEADER SIGNALING PROTEIN 19-APR-11 2YGN TITLE WIF DOMAIN OF HUMAN WNT INHIBITORY FACTOR 1 IN COMPLEX WITH 1,2- TITLE 2 DIPALMITOYLPHOSPHATIDYLCHOLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: WNT INHIBITORY FACTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: WIF DOMAIN, RESIDUES 35-178; COMPND 5 SYNONYM: WIF-1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: N-ACETYLGLUCOSAMINYLTRANSFERASE I- SOURCE 9 NEGATIVE HEK 293S GNTI(-)CELLS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PHLSEC KEYWDS SIGNALING PROTEIN, WNT SIGNALING PATHWAY, WNT ANTAGONIST, MORPHOGEN, KEYWDS 2 CANCER, GLYCOSAMINOGLYCAN EXPDTA X-RAY DIFFRACTION AUTHOR T.MALINAUSKAS,A.R.ARICESCU,W.LU,C.SIEBOLD,E.Y.JONES REVDAT 4 20-DEC-23 2YGN 1 HETSYN REVDAT 3 29-JUL-20 2YGN 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 17-AUG-11 2YGN 1 JRNL REVDAT 1 20-JUL-11 2YGN 0 JRNL AUTH T.MALINAUSKAS,A.R.ARICESCU,W.LU,C.SIEBOLD,E.Y.JONES JRNL TITL MODULAR MECHANISM OF WNT SIGNALING INHIBITION BY WNT JRNL TITL 2 INHIBITORY FACTOR 1 JRNL REF NAT.STRUCT.MOL.BIOL. V. 18 886 2011 JRNL REFN ISSN 1545-9993 JRNL PMID 21743455 JRNL DOI 10.1038/NSMB.2081 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 16407 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 828 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.5318 - 3.3602 1.00 2938 142 0.1869 0.1713 REMARK 3 2 3.3602 - 2.6678 0.99 2795 140 0.1894 0.2338 REMARK 3 3 2.6678 - 2.3307 0.97 2701 136 0.2077 0.2461 REMARK 3 4 2.3307 - 2.1177 0.93 2572 150 0.2179 0.2565 REMARK 3 5 2.1177 - 1.9660 0.89 2466 134 0.2448 0.3191 REMARK 3 6 1.9660 - 1.8501 0.77 2107 126 0.3366 0.4037 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 43.12 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.390 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 18.75330 REMARK 3 B22 (A**2) : -13.98480 REMARK 3 B33 (A**2) : -4.76850 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.015 1245 REMARK 3 ANGLE : 2.224 1673 REMARK 3 CHIRALITY : 0.141 186 REMARK 3 PLANARITY : 0.009 202 REMARK 3 DIHEDRAL : 21.154 483 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -3.1903 -17.5302 15.0452 REMARK 3 T TENSOR REMARK 3 T11: 0.2686 T22: 0.2520 REMARK 3 T33: 0.2591 T12: -0.0200 REMARK 3 T13: -0.0189 T23: -0.0023 REMARK 3 L TENSOR REMARK 3 L11: 1.5263 L22: 1.0058 REMARK 3 L33: 1.5368 L12: 0.0931 REMARK 3 L13: 0.1551 L23: -0.4158 REMARK 3 S TENSOR REMARK 3 S11: -0.0456 S12: -0.0482 S13: 0.1734 REMARK 3 S21: 0.0093 S22: 0.0150 S23: -0.0629 REMARK 3 S31: -0.3150 S32: 0.0817 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2YGN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-APR-11. REMARK 100 THE DEPOSITION ID IS D_1290048066. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17655 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.70000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2D3J REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000 30 % W/V, 200 MM SODIUM REMARK 280 ACETATE, 100 MM SODIUM CACODYLATE PH 6.5 . REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 24.95600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 67.06900 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 24.95600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 67.06900 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 24.95600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 67.06900 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 24.95600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 67.06900 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -24.95600 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -67.06900 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 32 REMARK 465 GLY A 179 REMARK 465 THR A 180 REMARK 465 LYS A 181 REMARK 465 HIS A 182 REMARK 465 HIS A 183 REMARK 465 HIS A 184 REMARK 465 HIS A 185 REMARK 465 HIS A 186 REMARK 465 HIS A 187 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2YGQ RELATED DB: PDB REMARK 900 WIF DOMAIN-EPIDERMAL GROWTH FACTOR (EGF)-LIKE DOMAINS 1-3 OF HUMAN REMARK 900 WNT INHIBITORY FACTOR 1 IN COMPLEX WITH 1,2- REMARK 900 DIPALMITOYLPHOSPHATIDYLCHOLINE REMARK 900 RELATED ID: 2YGO RELATED DB: PDB REMARK 900 WIF DOMAIN-EGF-LIKE DOMAIN 1 OF HUMAN WNT INHIBITORY FACTOR 1 IN REMARK 900 COMPLEX WITH 1,2- DIPALMITOYLPHOSPHATIDYLCHOLINE REMARK 900 RELATED ID: 2YGP RELATED DB: PDB REMARK 900 WIF DOMAIN-EGF-LIKE DOMAIN 1 MET77TRP OF HUMAN WNT INHIBITORY REMARK 900 FACTOR 1 IN COMPLEX WITH 1,2- DIPALMITOYLPHOSPHATIDYLCHOLINE REMARK 999 REMARK 999 SEQUENCE REMARK 999 ISOFORM Q166K. CRYSTALLISATION CONSTRUCT CONTAINS N- REMARK 999 TERMINAL ETG AND C-TERMINAL GTKHHHHHH AMINO ACID RESIDUES REMARK 999 DERIVED FROM THE EXPRESSION VECTOR. DBREF 2YGN A 35 178 UNP Q9Y5W5 WIF1_HUMAN 35 178 SEQADV 2YGN GLU A 32 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN THR A 33 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN GLY A 34 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN MLY A 166 UNP Q9Y5W5 GLN 166 VARIANT SEQADV 2YGN GLY A 179 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN THR A 180 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN LYS A 181 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN HIS A 182 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN HIS A 183 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN HIS A 184 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN HIS A 185 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN HIS A 186 UNP Q9Y5W5 EXPRESSION TAG SEQADV 2YGN HIS A 187 UNP Q9Y5W5 EXPRESSION TAG SEQRES 1 A 156 GLU THR GLY SER LEU TYR LEU TRP ILE ASP ALA HIS GLN SEQRES 2 A 156 ALA ARG VAL LEU ILE GLY PHE GLU GLU ASP ILE LEU ILE SEQRES 3 A 156 VAL SER GLU GLY MLY MET ALA PRO PHE THR HIS ASP PHE SEQRES 4 A 156 ARG MLY ALA GLN GLN ARG MET PRO ALA ILE PRO VAL ASN SEQRES 5 A 156 ILE HIS SER MET ASN PHE THR TRP GLN ALA ALA GLY GLN SEQRES 6 A 156 ALA GLU TYR PHE TYR GLU PHE LEU SER LEU ARG SER LEU SEQRES 7 A 156 ASP MLY GLY ILE MET ALA ASP PRO THR VAL ASN VAL PRO SEQRES 8 A 156 LEU LEU GLY THR VAL PRO HIS MLY ALA SER VAL VAL GLN SEQRES 9 A 156 VAL GLY PHE PRO CYS LEU GLY MLY GLN ASP GLY VAL ALA SEQRES 10 A 156 ALA PHE GLU VAL ASP VAL ILE VAL MET ASN SER GLU GLY SEQRES 11 A 156 ASN THR ILE LEU MLY THR PRO GLN ASN ALA ILE PHE PHE SEQRES 12 A 156 LYS THR CYS GLN GLY THR LYS HIS HIS HIS HIS HIS HIS MODRES 2YGN ASN A 88 ASN GLYCOSYLATION SITE MODRES 2YGN MLY A 62 LYS N-DIMETHYL-LYSINE MODRES 2YGN MLY A 72 LYS N-DIMETHYL-LYSINE MODRES 2YGN MLY A 111 LYS N-DIMETHYL-LYSINE MODRES 2YGN MLY A 130 LYS N-DIMETHYL-LYSINE MODRES 2YGN MLY A 143 LYS N-DIMETHYL-LYSINE MODRES 2YGN MLY A 166 LYS N-DIMETHYL-LYSINE HET MLY A 62 11 HET MLY A 72 11 HET MLY A 111 11 HET MLY A 130 11 HET MLY A 143 11 HET MLY A 166 11 HET PCF A1179 50 HET NAG A1180 14 HET ACT A1181 4 HETNAM MLY N-DIMETHYL-LYSINE HETNAM PCF 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ACT ACETATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 MLY 6(C8 H18 N2 O2) FORMUL 2 PCF C40 H80 N O8 P FORMUL 3 NAG C8 H15 N O6 FORMUL 4 ACT C2 H3 O2 1- FORMUL 5 HOH *83(H2 O) HELIX 1 1 ASP A 41 GLY A 50 1 10 HELIX 2 2 PRO A 65 HIS A 68 5 4 HELIX 3 3 ASP A 69 ARG A 76 1 8 SHEET 1 AA 6 MLY A 62 MET A 63 0 SHEET 2 AA 6 ILE A 55 SER A 59 -1 O SER A 59 N MLY A 62 SHEET 3 AA 6 LEU A 36 ILE A 40 -1 O LEU A 38 N ILE A 57 SHEET 4 AA 6 SER A 86 ALA A 93 -1 O THR A 90 N TRP A 39 SHEET 5 AA 6 SER A 132 GLY A 137 -1 O SER A 132 N TRP A 91 SHEET 6 AA 6 THR A 118 VAL A 119 -1 O THR A 118 N GLY A 137 SHEET 1 AB 4 LEU A 124 THR A 126 0 SHEET 2 AB 4 TYR A 99 SER A 108 -1 O TYR A 101 N GLY A 125 SHEET 3 AB 4 GLY A 146 ASN A 158 -1 O GLU A 151 N ARG A 107 SHEET 4 AB 4 THR A 163 MLY A 166 -1 N ILE A 164 O VAL A 156 SHEET 1 AC 4 LEU A 124 THR A 126 0 SHEET 2 AC 4 TYR A 99 SER A 108 -1 O TYR A 101 N GLY A 125 SHEET 3 AC 4 GLY A 146 ASN A 158 -1 O GLU A 151 N ARG A 107 SHEET 4 AC 4 PHE A 173 CYS A 177 -1 O PHE A 173 N PHE A 150 SHEET 1 AD 2 THR A 163 MLY A 166 0 SHEET 2 AD 2 GLY A 146 ASN A 158 -1 O VAL A 156 N ILE A 164 SSBOND 1 CYS A 140 CYS A 177 1555 1555 2.03 LINK C GLY A 61 N MLY A 62 1555 1555 1.34 LINK C MLY A 62 N MET A 63 1555 1555 1.34 LINK C ARG A 71 N MLY A 72 1555 1555 1.34 LINK C MLY A 72 N ALA A 73 1555 1555 1.35 LINK ND2 ASN A 88 C1 NAG A1180 1555 1555 1.45 LINK C ASP A 110 N MLY A 111 1555 1555 1.34 LINK C MLY A 111 N GLY A 112 1555 1555 1.34 LINK C HIS A 129 N MLY A 130 1555 1555 1.33 LINK C MLY A 130 N ALA A 131 1555 1555 1.34 LINK C GLY A 142 N MLY A 143 1555 1555 1.35 LINK C MLY A 143 N GLN A 144 1555 1555 1.35 LINK C LEU A 165 N MLY A 166 1555 1555 1.35 LINK C MLY A 166 N THR A 167 1555 1555 1.33 CRYST1 49.912 134.138 60.378 90.00 90.00 90.00 C 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020035 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007455 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016562 0.00000